Innoviva Inc (INVA)
19.06
-0.09
(-0.47%)
USD |
NASDAQ |
Nov 21, 16:00
19.08
+0.02
(+0.08%)
After-Hours: 20:00
Innoviva Profit Margin (Quarterly): 1.36% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.36% |
| June 30, 2024 | -34.72% |
| March 31, 2024 | 47.14% |
| December 31, 2023 | 71.68% |
| September 30, 2023 | |
| June 30, 2023 | 1.58% |
| March 31, 2023 | 45.65% |
| December 31, 2022 | -103.8% |
| September 30, 2022 | |
| June 30, 2022 | 0.87% |
| March 31, 2022 | 17.51% |
| December 31, 2021 | 9.61% |
| September 30, 2021 | 74.02% |
| June 30, 2021 | 88.24% |
| March 31, 2021 | |
| December 31, 2020 | 59.58% |
| September 30, 2020 | 31.82% |
| June 30, 2020 | 97.34% |
| March 31, 2020 | 83.17% |
| December 31, 2019 | 60.48% |
| September 30, 2019 | 60.54% |
| June 30, 2019 | 58.87% |
| March 31, 2019 | 61.23% |
| December 31, 2018 | |
| September 30, 2018 | 76.34% |
| Date | Value |
|---|---|
| June 30, 2018 | 81.43% |
| March 31, 2018 | 56.47% |
| December 31, 2017 | 83.98% |
| September 30, 2017 | 48.86% |
| June 30, 2017 | 60.02% |
| March 31, 2017 | 41.60% |
| December 31, 2016 | 58.40% |
| September 30, 2016 | 45.13% |
| June 30, 2016 | 44.95% |
| March 31, 2016 | 18.34% |
| December 31, 2015 | 18.83% |
| September 30, 2015 | -33.80% |
| June 30, 2015 | -73.30% |
| March 31, 2015 | -154.7% |
| December 31, 2014 | -218.8% |
| September 30, 2014 | -2.13K% |
| June 30, 2014 | -6.81K% |
| March 31, 2014 | |
| December 31, 2013 | -3.39K% |
| September 30, 2013 | -11.32K% |
| June 30, 2013 | -2.76K% |
| March 31, 2013 | -2.78K% |
| December 31, 2012 | 25.19% |
| September 30, 2012 | -2.43K% |
| June 30, 2012 | -2.60K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-103.8%
Minimum
Dec 2022
97.34%
Maximum
Jun 2020
32.44%
Average
45.65%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 9.67% |
| Return on Assets | 5.25% |
| Return on Invested Capital | 5.79% |
| Gross Profit Margin (Quarterly) | 88.84% |
| Operating Margin (Quarterly) | 48.31% |
| Return on Net Operating Assets | 17.35% |